高醫造血幹細胞移植~愛相髓 與 Breast Cancer Survivorship 使用情況與統計

目前中華民國血液及骨髓移植學會(2020)統計顯示從1983年至2020年台灣共完成8747例造血幹細胞移植,尤其是2009年至2020年期間完成5901例。隨著移植技術日益進步,死亡率降低,但治療過程中亦可能帶來副作用及合併症,可能會造成病人生理、心理、社會及靈性影響及衝擊。故自移植前既由醫護人員開始提供此自我照顧APP介入,給予相對應的醫療資訊及心理諮詢,包含:造血幹細胞移植的認識、移植前評估、移植室環境介紹、移植前自我準備、移植前調理治療、造血幹細胞重生日、移植併發症及治療、移植後追蹤項目、Q&A、任務/問卷區、個人專區、自我照護及圖表資料,以適時提供整合性照護。 ---------------------------------------- 免責聲明 此應用程序提供資訊僅供參考,在做出任何醫療決定之前,請尋求醫生的諮詢、診斷或建議的治療。 ----------------------------------------
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

About Us “Thrive HKU” is an initiative mobile application of The Department of Clinical Oncology, LKS Faculty of Medicine of the University of Hong Kong. “Thrive HKU” aims to provides better support for breast cancer survivors both physically and psychologically. “Thrive HKU” equips breast cancer survivors with educational materials on breast cancer management and psychological support. Registered users will be given a Pink Fitbit which can encourage them to have more exercises and have a healthy lifestyle. We wish breast cancer survivors who use the thrive app and Pink Fitbit every day can have a bright and healthy future! Disclaimer The information contained in this App is for general educational purpose and reference only. Such information is not medical advice, diagnosis or treatment on any individual case or patient and should not be treated as a substitute for professional medical advice, diagnosis or treatment. You should consult your attending doctor or health professional for any medical condition that you may have, rather than relying on the information provided in this App.
  • Apple App Store
  • 免費版
  • 健康與健身

商店排名

- -

高醫造血幹細胞移植~愛相髓與 Breast Cancer Survivorship 比較排名

比較過去 28 天的 高醫造血幹細胞移植~愛相髓 排名趨勢與 Breast Cancer Survivorship

排名

無可用數據

各國 高醫造血幹細胞移植~愛相髓 vs. Breast Cancer Survivorship 排名比較

比較過去 28 天的 高醫造血幹細胞移植~愛相髓 排名趨勢與 Breast Cancer Survivorship

無可顯示數據

使用我們的免費試用版,與所有網站進行比較

立即開始
高醫造血幹細胞移植~愛相髓 VS.
Breast Cancer Survivorship

12月 19, 2024